Cytometry Part B-Clinical Cytometry

Papers
(The median citation count of Cytometry Part B-Clinical Cytometry is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Issue highlights—January 202545
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease43
31
An uncommon case of acute megakaryoblastic leukemia with DDX3X :: MLLT10 30
28
Diagnostic workflow for X‐linked agammaglobulinemia integrating BTK expression and B‐cell maturation analysis by flow cytometry19
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells19
18
Issue highlights—September 202317
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients17
16
Issue Information16
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma15
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel15
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia15
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi14
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis12
Defining atypical chronic lymphocytic leukemia for reproducible diagnosis: implications of the work by Wang et al.12
Issue Information12
Standardization of flow cytometric detection of antigen expression12
Issue Information12
Basophilic blast crisis of chronic myelogenous leukemia presenting de novo: Diagnostic contribution of flow cytometry11
Issue Information11
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric10
Issue Information10
Integrating immune profiling and clinical features for early prediction of chronicity in pediatric immune thrombocytopenia9
CD133 in T ‐lymphoblastic leukemia is preferentially expressed in early T 9
Issue Information9
ROR1 expression in mature B lymphoid neoplasms by flow cytometry9
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry9
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR9
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT8
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet8
Issue Information8
SingletSeeker: An unsupervised clustering approach for automated singlet discrimination in cytometry8
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia8
A novel flow cytometry approach to quantify malaria‐derived particles8
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays8
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis7
Implementation of a one‐tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine7
7
Anti‐ CD38 VHH antibody ( JK36 ) reliably detects CD38 7
6
International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories6
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry6
Issue Information6
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience5
Monocyte maturation pattern by flow cytometry expression of CD64 , CD300e , and 5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care5
Exercise affects systemic basophil responses in humans: Applying an automated and modified basophil activation test ( mBAT ) in a field study5
Optimizing the diagnosis of chronic granulomatous disease using dihydrorhodamine‐123 assay: Lessons from a large monocentric cohort5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup5
Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia5
Characterization of CD123 expression by mast cells in systemic mastocytosis with multicolor flow cytometry5
Editorial on IVD cellular assay validation5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry5
Issue Highlights—July 20225
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis4
Issue Information4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia4
Issue Highlights—July 20254
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry4
4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
Flow cytometry‐based monitoring of chimeric antigen receptor ( CAR ) T cells: Reagent selection, assay design, and clinical utility4
4
Issue Highlights—November 20254
Mature T‐cell leukemia/lymphoma with an NK ‐like immunophenotype: A report of 7 cases4
Issue highlights—November 20244
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma4
Signal without noise: Practical antibody titration for platelet flow cytometry4
Stabilization of bronchoalveolar lavage cells for postponed flow cytometric analysis4
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis4
Analysis of immunophenotypic changes in acute megakaryoblastic leukemia after treatment4
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder3
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease3
Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease3
3
Issue highlights—May 20233
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern3
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms3
Highlights May 20263
Issue highlights—July 20243
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent3
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia3
Flow cytometry in the diagnosis of myelodysplastic syndromes3
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study3
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions3
3
Establishment of pediatric reference ranges for circulating naïve and memory T and B cell subsets guided by the human immunophenotyping consortium standardization initiative: A large, single center U.3
Measurable residual disease by multicolor flow cytometry in acute myeloid leukemia: A comparison of peripheral blood and bone marrow3
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow2
Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia2
Challenges and approaches in the diagnosis and differential diagnosis of atypical CLL : A response to ‘Defining atypical CLL2
Recommendations for using artificial intelligence in clinical flow cytometry2
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall2
Issue highlights—July 20232
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients2
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection2
2
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience2
Issue Information2
Issue highlights—September 20242
Optimization and validation of a flow cytometry‐based HLA ‐ B27 assay on 2
2
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow2
Establishment of a flow cytometric platelet crossmatching assay and its clinical application in platelet refractoriness2
Comment on “An unusual pattern observed upon the addition of CD79b to a flow‐Cytometry B‐cell Lymphoma panel” ( Cytometry B Cl2
Issue Information2
Issue Information2
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma2
CD200 expression in CD4 + T‐cells: Diagnostic implications across T‐cell lymphomas2
To fret over FRET : Unintended fluorescence energy transfer artifacts and their implications for flow cytometry panel design and interpretation as hi2
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy2
The role of CD20+ T cells: Insights in human peripheral blood1
Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country1
Therapy‐related B ‐lymphoblastic leukemia/lymphoma with MYC 1
AI in flow cytometry: Current applications and future directions1
Immunophenotypic characteristics of plasma cells in POEMS syndrome1
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di1
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry1
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data1
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry1
Automation in flow cytometry: Guidelines and review of systems1
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia1
Authors' Response to Letter from Khanolkar and Ahmed concerning our article “An unusual pattern observed upon the addition of CD79b to a flow cytomet1
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transp1
Noel Warner Ph.D.1
Issue Information1
Issue Information1
“What are we measuring?” reconsidering the biological identity and clinical interpretation of malaria‐derived particles1
Bridging the implementation gap in AI ‐assisted flow cytometry1
Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders1
Issue Highlights—September 20221
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry1
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS1
Circulating monocyte partitioning and its alteration in hematological chronic neoplasms1
Artificial Intelligence Issue Highlights1
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands1
Issue highlights—November 20221
De novo acute myeloid leukemia harboring concurrent CBFA2T3 :: 1
Standardizing stem cell enumeration: A methodological comparison of single and dual flow cytometry platforms1
Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome1
0.094367980957031